V. V. Fomin
|
|
N.A. Mukhin
Fever Of Unknown Origin
|
9-14 |
M.A. Domashenko, M.Yu. Maksimova, S.V. Orlov, E.P. Shcukina, E.M. Goncharova
Poststroke Depression
|
15-19 |
I.V. Damulin
Cognitive Impairment In Cerebrovascular Diseases: Some Aspects Of Diagnosis And Treatment
|
20-28 |
V.V. Gudkova, T.V. Shanina, K.V. Stakhovskaya
Cytoprotective Properties Of Citicoline: Experimental Prerequisites And Clinical Results
|
29-34 |
I.V. Merkushkina
Problems Of Discogenic Dorsalgia: Pathogenesis, Clinical Picture And Treatment
|
35-44 |
O.V. Kotova
Application Of Nsaids In The Treatment Of Pain Syndromes
|
45-48 |
G.R. Tabeeva, Yu. Azimova
Therapy Of Tension-type Headache
|
50-54 |
M.I. Koreshkina
Use Of Headache Diary For Diagnosis And Treatment Of Migraine
|
55-60 |
T.R. Zharkova
Neurotropic Therapy Of Sensory Deficit In Patients With Radiculopathy
|
61-65 |
A.O. Lisitcin
Ibuprofen In The Treatment Of Inflammatory Diseases Of Joints In Children
|
66-69 |
V.V. Vasilenko
Sore Throat: Causes And Potentials For Relief
|
70-73 |
A.S. Mikhay’lova, O.V. Teplyakova, L.A. Sokolova
Effect Of Local Therapy Of Gonarthrosis By Hyaluronic Acid Preparations Of Various Molecular Weights On Dynamics Of Algofunctional Measures
|
74-78 |
O.V. Dobrovol’skaya, N.V. Toroptcova, O.A. Nikitinskaya, N.V. Demin
Pathogenetic Treatment Of Osteoporotic Vertebral Fractures In Real-life Clinical Practice
|
80-84 |
I.E. Poverennova, A.V. Yakunina, V.A. Kalinin, E.K. Muromtceva, E.M. Beketova
Results Of Treatment Of Epilepsy In Different Age Groups
|
85-89 |
V.A. Karlov, N.V. Freydkova, I.A. Zhidkova, Yu.M. Polenova, L.V. Rusanova
Evaluation Of Efficacy Of Topiramate In Prolonged Treatment Of Epilepsy
|
90-94 |
V.V. Rusaya, O.V. Vorob’yova
Quality Of Life In Patients With Panic Disorder, And Its Determinant Factors
|
96-100 |
M.A. Elfimov
Basic Principles And Efficacy Of Use Of Antihomotoxic Drugs In The Structure Of Restorative Treatment Of Patients With Post-traumatic Borderline Personality Disorders
|
102-106 |
N.V. Matveev
Evaluation Of The Clinical And Economic Efficiency Of Pharmacotherapy Of Diabetic Polyneuropathy
|
107-111 |